Concepedia

Publication | Open Access

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

DOIFull Paper Access

247

Citations

19

References

2016

Year

Sherif Gonem, Rachid Berair, Amisha Singapuri, Ruth Hartley, Marie Laurencin, Gerald Bacher, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord,
The Lancet Respiratory Medicine

Abstract

Novartis Pharmaceuticals, AirPROM project, and the UK National Institute for Health Research.

References

YearCitations

Page 1